Experimental obesity drug leads to 24.2 per cent weight loss in trial

By Bloomberg

Eli Lilly’s retatrutide showed the effects after 48 weeks, surpassing results seen with other such medications.

Source: Experimental obesity drug leads to 24.2 per cent weight loss in trial